Inpharma Weekly

, Volume 962, Issue 1, pp 20–21 | Cite as

Minimising the GI risks of NSAIDs

  • Rosie Stather
Newsletter Article


The risks posed by NSAIDs on the gastrointestinal tract are well known. However, ways of minimising these risks are less clear. Can an effective prophylactic agent be found? Can new types of NSAIDs be developed that are less harmful to the gut? Where is the damage actually occurring? Answers to these, and other, questions were put forward at a session devoted to the risks and benefits of NSAIDs at the 10th World Congress of Gastroenterology [ Los Angeles, USA; October 1994 ].


Duodenal Ulcer Famotidine Nsaid User Gastric Damage Arachidonic Acid Release 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 1994

Authors and Affiliations

  • Rosie Stather

There are no affiliations available

Personalised recommendations